News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,354 Results
Type
Article (39570)
Company Profile (247)
Press Release (656537)
Section
Business (204128)
Career Advice (2007)
Deals (35413)
Drug Delivery (94)
Drug Development (81009)
Employer Resources (172)
FDA (16155)
Job Trends (14844)
News (345072)
Policy (32500)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2548)
Accelerated approval (4)
Adcomms (20)
Allergies (80)
Alliances (49375)
ALS (83)
Alzheimer's disease (1354)
Antibody-drug conjugate (ADC) (109)
Approvals (16157)
Artificial intelligence (230)
Autoimmune disease (16)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (249)
Cancer (2009)
Cardiovascular disease (162)
Career advice (1673)
Career pathing (29)
CAR-T (140)
Cell therapy (396)
Cervical cancer (19)
Clinical research (65727)
Collaboration (768)
Compensation (463)
Complete response letters (19)
COVID-19 (2581)
CRISPR (35)
C-suite (211)
Cystic fibrosis (98)
Data (1977)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (249)
Diagnostics (6339)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (112)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86213)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111693)
Executive appointments (647)
FDA (17270)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (687)
Gene editing (96)
Generative AI (18)
Gene therapy (278)
GLP-1 (685)
Government (4380)
Grass and pollen (4)
Guidances (49)
Healthcare (18811)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2713)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (87)
Interviews (311)
IPO (16484)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (454)
Leadership (15)
Legal (7900)
Liver cancer (70)
Lung cancer (292)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (267)
MASH (61)
Medical device (13326)
Medtech (13331)
Mergers & acquisitions (19404)
Metabolic disorders (632)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (80)
Neuropsychiatric disorders (24)
Neuroscience (1835)
NextGen: Class of 2025 (6515)
Non-profit (4481)
Northern California (2439)
Now hiring (37)
Obesity (340)
Opinion (202)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (135)
Partnered (20)
Patents (204)
Patient recruitment (96)
Peanut (46)
People (57113)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20470)
Phase II (28943)
Phase III (21572)
Pipeline (1052)
Podcasts (45)
Policy (113)
Postmarket research (2563)
Preclinical (8657)
Press Release (64)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (359)
Real estate (5901)
Recruiting (65)
Regulatory (22147)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2111)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3573)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (27)
United States (21248)
Vaccines (657)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (122)
Last 7 days (691)
Last 30 days (2718)
Last 365 days (33568)
2025 (8171)
2024 (35220)
2023 (40077)
2022 (51174)
2021 (55713)
2020 (54087)
2019 (46545)
2018 (35026)
2017 (32114)
2016 (31482)
2015 (37558)
2014 (31322)
2013 (26349)
2012 (28573)
2011 (29273)
2010 (27332)
Location
Africa (718)
Alabama (49)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (37709)
Australia (6166)
California (5553)
Canada (1873)
China (475)
Colorado (247)
Connecticut (256)
Delaware (128)
Europe (80865)
Florida (825)
Georgia (194)
Idaho (57)
Illinois (499)
India (24)
Indiana (291)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (61)
Maryland (831)
Massachusetts (4180)
Michigan (209)
Minnesota (370)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1587)
New Mexico (28)
New York (1599)
North Carolina (921)
North Dakota (7)
Northern California (2439)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1259)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2111)
Tennessee (93)
Texas (830)
Utah (164)
Virginia (130)
Washington D.C. (57)
Washington State (513)
West Virginia (3)
Wisconsin (49)
696,354 Results for "beckman coulter inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
March 10, 2025
·
4 min read
Press Releases
Beckman Coulter Receives FDA Breakthrough Device Designation for Alzheimer’s Disease Blood Test
January 29, 2025
·
4 min read
Policy
Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
Beckman Coulter, a global leader in clinical diagnostics, announced U.S. Food and Drug Administration clearance of its Access NT-proBNP assay for the assessment of heart failure in less than 11 minutes on the Beckman Coulter DxI 9000 Immunoassay Analyzer*.
May 29, 2024
·
3 min read
Press Releases
Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
January 16, 2025
·
5 min read
Business
Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced expansion of their host immune response diagnostics partnership.
May 7, 2024
·
5 min read
Beckman Coulter’s DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced , ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases, that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.
April 16, 2024
·
4 min read
Business
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics - March 12, 2024
Beckman Coulter Diagnostics today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
March 12, 2024
·
4 min read
Business
Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President
Beckman Coulter Diagnostics announced Kevin O’Reilly’s appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive, Danaher Diagnostics.
February 6, 2024
·
3 min read
Biotech Beach
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic manufacturing, announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
March 12, 2024
·
4 min read
Press Releases
BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests
October 29, 2024
·
4 min read
1 of 69,636
Next
